DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Funds / Merck Lumira Biosciences Fund Limited Partnership
Merck Lumira Biosciences Fund Limited Partnership
Amounts, each with its basis
- Vintage
- unknownno dated first sale or first report yet
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- unknownwhat may be sold, not what was raised
- Form D sold
- unknown
- First sale
- unknown
- Reported GAV
- $28.2Mon the Form ADV filed Mar 25, 2024; the fund's assets, never its size or dry powder
- Owners (ADV)
- 4
- Reported on ADV
- May 14, 2012 to Mar 25, 2024
Fundraising evidence
Unknown
no Form D or close on record (fr-1)
A Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.
Lifecycle
Unknown
no vintage and no recent Form D
first sale: n/avintage year: n/aadv gav as of: 2024-03-25vintage basis: n/aform d sold usd: n/aform d offering usd: n/aform d latest filed at: n/a
The fund's own reporting through time
16 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| May 14, 2012 | Venture Capital Fund | $0 | 4 | $5.0M | 0% | yes | |
| Jun 12, 2012 | Venture Capital Fund | $0 | 4 | $5.0M | 0% | yes | |
| Feb 20, 2013 | Venture Capital Fund | $0 | 4 | $5.0M | 0% | yes | |
| Mar 18, 2013 | Venture Capital Fund | $0 | 4 | $5.0M | 0% | yes | |
| Oct 21, 2013 | Venture Capital Fund | $2.0M | 4 | $5.0M | 0% | yes | |
| Mar 26, 2014 | Venture Capital Fund | $5.0M | 4 | $5.0M | 0% | yes | |
| Mar 27, 2015 | Venture Capital Fund | $9.9M | 4 | $5.0M | 0% | yes | |
| Mar 24, 2016 | Venture Capital Fund | $14.0M | 4 | $5.0M | 0% | yes | |
| Mar 10, 2017 | Venture Capital Fund | $11.4M | 4 | $5.0M | 0% | yes | |
| Mar 5, 2018 | Venture Capital Fund | $14.0M | 4 | $5.0M | 0% | yes | |
| Mar 26, 2019 | Venture Capital Fund | $26.7M | 4 | $5.0M | 0% | yes | |
| Mar 11, 2020 | Venture Capital Fund | $27.7M | 4 | $5.0M | 0% | yes | |
| Mar 31, 2021 | Venture Capital Fund | $29.5M | 4 | $5.0M | 0% | yes | |
| Mar 30, 2022 | Venture Capital Fund | $29.8M | 4 | $5.0M | 0% | yes | |
| Mar 28, 2023 | Venture Capital Fund | $32.7M | 4 | $5.0M | 0% | yes | |
| Mar 25, 2024 | Venture Capital Fund | $28.2M | 4 | $5.0M | 0% | yes |
Principals and agents
0 principals on Form D, 0 placement agents
No Form D related person on record.
Limited partners and their reported performance
0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
1 events
- May 14, 2012Merck Lumira Biosciences Fund Limited Partnership first reported on Form ADV by Lumira Capital (Venture Capital Fund)Fund first reported on Form ADV Fact SEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Evidence
0 observations